Inventor
WOLLOWITZ SUSAN
US36 patents
⚠️ This page may combine multiple inventors who share the name “WOLLOWITZ SUSAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CERUS CORP
25 patentsUS5691132ANov 25, 1997
Method for inactivating pathogens in red cell compositions using quinacrine mustard
CERUS CORP83 citations97
US6503699B1Jan 7, 2003
Method for photodecontamination of pathogens in blood using 5'-primary aminopsoralens
CERUS CORP33 citations96
US6469052B2Oct 22, 2002
Compounds for the photodecontamination of pathogens in blood
CERUS CORP33 citations96
US6410219B1Jun 25, 2002
Treating blood or blood products with compounds which have a mustard, azirdinium or aziridine group and a nucleic acid binding group
CERUS CORP54 citations96
US6218100B1Apr 17, 2001
5′-primary aminoalkyl psoralen compositions with platelets
CERUS CORP42 citations96
US6194139B1Feb 27, 2001
Methods for photodecontamination of pathogens in blood
CERUS CORP34 citations96
US6177441B1Jan 23, 2001
Treating red blood cell solutions with anti-viral agents
CERUS CORP58 citations96
US6171777B1Jan 9, 2001
Treating blood or blood product with a compound having a mustard and a nucleic acid binding moiety
CERUS CORP68 citations96
US6143490ANov 7, 2000
Treating blood or blood product with a compound having a mustard and a nucleic acid binding moiety
CERUS CORP48 citations96
US6017691AJan 25, 2000
4'-primary aminopsoralen and platelet compositions
CERUS CORP58 citations96
US5871900AFeb 16, 1999
Method of inactivating pathogens in biological fluids using photoactivated 5-primaryamino psoralens
CERUS CORP70 citations96
US5712085AJan 27, 1998
5'-(4-amino-2-oxa)butye-4,4', 8-trinethylpsoralen in synthetic medium
CERUS CORP57 citations96
US5654443AAug 5, 1997
Compounds for the photo decontamination of pathogens in blood
CERUS CORP45 citations96
US5625079AApr 29, 1997
Synthesizing psoralen compounds useful as intermediates
CERUS CORP48 citations96
US6093725AJul 25, 2000
Frangible compounds for pathogen inactivation
CERUS CORP69 citations95
US5593823AJan 14, 1997
Method for inactivating pathogens in blood using photoactivation of 4'-primary amino-substituted psoralens
CERUS CORP109 citations95
US6686480B2Feb 3, 2004
Compounds for the photodecontamination of pathogens in blood
CERUS CORP33 citations93
US6420570B1Jul 16, 2002
Psoralen compounds
CERUS CORP34 citations93
US6004742ADec 21, 1999
Method for inactivation of pathogens in platelets using 4' and 5' primary amino-substituted psoralens
CERUS CORP30 citations93
US6004741ADec 21, 1999
Method for the photoactivation of 4' and 5' primary aminoalkyl psoralens in platelet preparations
CERUS CORP35 citations93
US5972593AOct 26, 1999
Method for the photo-decontamination of pathogens in blood using 4'-primary amino psoralens
CERUS CORP25 citations93
US6514987B1Feb 4, 2003
Frangible compounds for pathogen inactivation
CERUS CORP52 citations92
US6455286B1Sep 24, 2002
Psoralens for pathogen inactivation
CERUS CORP26 citations92
US6133460AOct 17, 2000
Psoralens for pathogen inactivation
CERUS CORP36 citations92
US6281225B1Aug 28, 2001
Inhibiting proliferation of arterial smooth muscle cells
CERUS CORP81 citations91
STERITECH INC
5 patentsUS5399719AMar 21, 1995
Compounds for the photodecontamination of pathogens in blood
STERITECH INC107 citations99
US5578736ANov 26, 1996
Compounds for the photo-decontamination of pathogens in blood
STERITECH INC31 citations96
US5559250ASep 24, 1996
Treating red blood cell solutions with anti-viral agents
STERITECH INC72 citations96
US5556993ASep 17, 1996
Compounds for the photodecontamination of pathogens in blood
STERITECH INC35 citations96
US5585503ADec 17, 1996
Compounds for the photodecontamination of pathogens in blood
STERITECH INC24 citations92